ICASA Updates – August 2011


Data sampling of the International ADHD in Substance use disorders Prevalence (IASP) study.

The 30st of September 2011 we will close data sampling for Norway, Sweden, the Netherlands, Belgium, France, Spain, Switzerland, Hungary, USA and Australia. After Switzerland in spring of 2011, now Spain finished their data sampling: they included 500 patients in the sample. In October 2011 we will now the preliminary results of the IASP. I will present some of the first figures during the 2nd International Conference on Dual Diagnoses in Barcelona, Spain, during our symposium on ADHD and Substance Abuse.

We will organize an extra ICASA meeting in December 2011, for discussing the IASP results. In addition to this meeting we will have writing sessions with a group of 10-15 experienced researchers. We want to have the results of the IASP out as soon as possible!

IASP II will start soon and is growing fast

Our colleagues in South Africa will start up the data sampling process for duplicating the IASP study in their country soon. Professor Alban Burke of the University of Johannesburg is in charge of the data sampling process there.

Currently I am travelling to Porto Alegre in Brazil. I am invited by dr. Claudia Szobot and prof. Luis Rohde of ProDAH - Programa de Déficit de Atenção/Hiperatividade (for information, please go to http://www6.ufrgs.br/prodah/prodah-e.html ), a huge and very important research program focusing at ADHD at the University of Porto Alegre. This research group will enroll the IASP study in several addiction treatment centers in their city. Over the next days I will post new blogs on my experiences in Brazil.
On 7th and 8th October I will present on ADHD and SUD during the National Conference of Psychiatrists in Alexandria, Egypt. During these days I will train a group of psychiatrists and psychologists who will duplicate the IASP in their country.

We are waiting for the decision of the Irish Consumer Organization for ADHD who asked researchers to submit a research proposal targeting on the prevalence of ADHD in treatment seeking SUD populations. We hope to be able to include this research in the IASP data base.

We intend to include these four countries in the next wave of the IASP study, adding up the total number of participants, and comparing the results of these new countries to the overall results. The strength of the IASP I and II is that all of the groups are using the same instruments and the same research protocol.

The Casp study takes off

In three countries, Hungary, Australia and the USA, data sampling started for the Continuous performance task in ADHD and SUD Patients (CASP) study. We will find out if a new Continuous Performance Task, the MOXO test can differentiate between patients with 1)ADHD and SUD, 2) SUD only and 3) healthy controls. We hope to be able to come up with some preliminary results soon. We’ll keep you posted.


Be the first to place a comment